Figure 3. Acute treatment with liraglutide significantly increases DCX-immunoreactive cells in the DG of both wild type and APP/PS1 at all ages.

^*p<0.05, ^**p<0.01 compared with saline control. Values are expressed as mean ± SEM (n = 6).